Back
Marinus Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
MRNS
Sponsored
Nvidia's march to $5 trillion
Click here to see how Nvidia's march to $5 trillion could impact its partners.
Sell
28
MRNS
Marinus Pharmaceuticals
Last Price:
1.20
Seasonality Move:
31.72%
7 Day Trial
ALL ACCESS PASS
$
7
A massive $1 Trillion AI superproject is underway
Click here to discover these key companies behind this $1 trillion SuperprojectMarinus Pharmaceuticals Price Quote
$1.20
+0.03 (+-2.44%)
(Updated: June 29, 2024 at 6:12 AM ET)
Marinus Pharmaceuticals Key Stats
Sell
28
Marinus Pharmaceuticals (MRNS)
is a Sell
Day range:
$1.10 - $1.28
52-week range:
$1.10 - $11.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.28
P/B ratio:
0%
Volume:
7.9M
Avg. volume:
1.3M
1-year change:
-89.33%
Market cap:
$64.3M
Revenue:
$31M
EPS:
$-2.64
How Much Does Marinus Pharmaceuticals Make?
-
How Much Are Marinus Pharmaceuticals's Sales Annually?
MRNS Revenues are $31M -
How Much Profit Does Marinus Pharmaceuticals's Make A Year?
MRNS net income is -$141.4M
Is Marinus Pharmaceuticals Growing As A Company?
-
What Is Marinus Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.26% -
What Is Marinus Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Marinus Pharmaceuticals Stock Price Performance
-
Did Marinus Pharmaceuticals Stock Go Up Last Month?
Marinus Pharmaceuticals share price went down by -22% last month -
Did MRNS's Share Price Rise Over The Last Year?
MRNS share price fell by -89.33% over the past 1 year
What Is Marinus Pharmaceuticals 52-Week High & Low?
-
What Is Marinus Pharmaceuticals’s 52-Week High Share Price?
Marinus Pharmaceuticals has traded as high as $11.26 over the past 52 weeks -
What Is Marinus Pharmaceuticals’s 52-Week Low Share Price?
Marinus Pharmaceuticals has traded as low as $1.10 over the past 52 weeks
Marinus Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Marinus Pharmaceuticals?
-
How Much Debt Does Marinus Pharmaceuticals Have?
Total long term debt quarterly is $73.5M -
How Much Cash Does Marinus Pharmaceuticals Have?
Cash and short term investments quarterly total is $113.3M -
What Is Marinus Pharmaceuticals’s Book Value Per Share?
Book value per share is -0.30
Is Marinus Pharmaceuticals Cash Flow Positive?
-
What Is MRNS Cash Flow From Operations?
Cash flow from operations (TTM) is -$114M -
What Is Marinus Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $27.1M -
What Is Marinus Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $44.3M
Marinus Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
MRNS return on invested capital is -129.53% -
What Is Marinus Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -77.55% -
What Is MRNS Return On Equity?
ROE is a measure of profitability and is -368.35%
Marinus Pharmaceuticals Earnings Date & Stock Price
-
What Is Marinus Pharmaceuticals's Stock Price Today?
A single share of MRNS can be purchased today for 1.17 -
What Is Marinus Pharmaceuticals’s Stock Symbol?
Marinus Pharmaceuticals trades on the nasdaq under the ticker symbol: MRNS -
When Is Marinus Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Marinus Pharmaceuticals is scheduled on August 9, 2024 -
When Is MRNS's next ex-dividend date?
Marinus Pharmaceuticals's next ex-dividend date is June 30, 2024 -
How To Buy Marinus Pharmaceuticals Stock?
You can buy Marinus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Marinus Pharmaceuticals Competitors
-
Who Are Marinus Pharmaceuticals's Competitors?
Below is a list of companies who compete with Marinus Pharmaceuticals or are related in some way:
Marinus Pharmaceuticals Dividend Yield
Data Unavailable
Marinus Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0.73% |
Revenue: | -26.02% | -15.51% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 6.67 |
Upside from Last Price: | 469.8% |